Por favor, use este identificador para citar o enlazar este ítem: http://sgc.anlis.gob.ar/handle/123456789/1508
Campo DC Valor Lengua/Idioma
dc.contributor.authorLaucella, Susana A.es
dc.contributor.authorRiarte, Adelinaes
dc.contributor.authorPrado, Nilda Gracielaes
dc.contributor.authorZapata, Jes
dc.contributor.authorSegura, Elsa L.es
dc.date.accessioned2019-12-13T18:41:13Z-
dc.date.available2019-12-13T18:41:13Z-
dc.date.issued2001-05-
dc.identifier.issn0300-9475-
dc.identifier.urihttp://sgc.anlis.gob.ar/handle/123456789/1508-
dc.description.abstractWe have previously shown that titers of soluble platelet selectin (s-P-selectin) and soluble vascular cell adhesion molecule-1 (s-VCAM-1) were increased in sera of patients with chronic Trypanosoma cruzi infection. In this study, we analyzed the expression of CD49d-integrins, that bind to VCAM-1, and sialyl Lewis x (SLe(x)), which binds selectins, in peripheral blood lymphocytes of 27 patients with Chagas' disease at different levels of disease severity. Patients with a mild form of Chagas' disease showed a lower number of CD49d(+) cells, in comparison with those with severe chronic cardiopathy. Decreased levels of CD49d(+) cells were detected in CD3(-) cell populations. Conversely, SLe(x) expression was found to be decreased in patients with severe Chagas' disease. Levels of soluble platelet endothelial cell adhesion molecule-1 (s-PECAM-1) were significantly increased in the plasma of patients with severe Chagas' disease while unaltered levels of MCP-1 were recorded. These data show that VCAM-1 and P-Selectin ligands are differentially expressed during the chronic phase of the Trypanosoma cruzi infection. These findings also reinforce a role of the P-selectin/SLe(x) adhesion pathway rather than very late antigen-4 (VLA-4)/VCAM-1, in the pathogenesis of Chagas' disease.en_US
dc.language.isoenes
dc.relation.ispartofScandinavian journal of immunologyen_US
dc.titlealpha 4 Integrins and sialyl Lewis x modulation in chronic Chagas disease: further evidence of persistent immune activationes
dc.typeArtículoes
dc.identifier.doi10.1046/j.1365-3083.2001.00916.x-
item.grantfulltextopen-
item.cerifentitytypePublications-
item.fulltextWith Fulltext-
item.languageiso639-1en-
item.openairetypeArtículo-
item.openairecristypehttp://purl.org/coar/resource_type/c_18cf-
crisitem.author.deptAdministración Nacional de Laboratorios e Institutos de Salud “Dr. Carlos G. Malbrán” (ANLIS)-
crisitem.author.deptInstituto Nacional de Parasitología (INP)-
crisitem.author.deptAdministración Nacional de Laboratorios e Institutos de Salud “Dr. Carlos G. Malbrán” (ANLIS)-
crisitem.author.deptInstituto Nacional de Parasitología (INP)-
crisitem.author.parentorgAdministración Nacional de Laboratorios e Institutos de Salud “Dr. Carlos G. Malbrán” (ANLIS)-
crisitem.author.parentorgAdministración Nacional de Laboratorios e Institutos de Salud “Dr. Carlos G. Malbrán” (ANLIS)-
Aparece en las colecciones: Publicaciones INP
Ficheros en este ítem:
Fichero Descripción Tamaño Formato
j.1365-3083.2001.00916.x.pdfArtículo en inglés153.44 kBAdobe PDFVista previa
Visualizar/Abrir
Mostrar el registro sencillo del ítem

Visualizaciones de página(s)

137
comprobado en 14-jun-2025

Descarga(s)

20
comprobado en 14-jun-2025

Google ScholarTM

Consultar

Altmetric

Altmetric


Los ítems de DSpace están protegidos por copyright, con todos los derechos reservados, a menos que se indique lo contrario.